SCHEMBL3252126

SCHEMBL3252126

CCCCCOc1ccc(NC(=O)N(S)C(=O)c2cc3cc(N(C)C)ccc3o2)cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OXTR P30559 2/20 0.43
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
DGAT1 O75907 1/20 0.36
MAPT P10636 3/20 0.36
THRB P10828 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35
MCL1 Q07820 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
POLB P06746 1/20 0.35
CSF1R P07333 1/20 0.34
LMNA P02545 1/20 0.33
ATM Q13315 2/20 0.33
SYK P43405 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2871069 0.83 MAPT (0.46) OXTRNPC1RAB9AMAPTKDM4E
SCHEMBL2943875 0.75 S1PR1 (0.44) MAPTSMN1; SMN2LMNA
SCHEMBL2944777 0.75 S1PR1 (0.44) MAPTSMN1; SMN2LMNA
SCHEMBL2871064 0.74 OXTR (0.39) OXTRNPC1RAB9AMAPTTHRB
SCHEMBL4518245 0.71 S1PR1 (0.50) NPC1RAB9AMAPTTHRBKDM4E
SCHEMBL3258642 0.71 ALDH1A1 (0.41) NPC1RAB9AMAPTALDH1A1HPGD
SCHEMBL2941558 0.70 TRPV1 (0.44) NPC1RAB9AALDH1A1SMN1; SMN2KMT2A
SCHEMBL4362063 0.69 MAPT (0.62) NPC1RAB9AMAPTKDM4EALDH1A1
SCHEMBL2872160 0.67 S1PR1 (0.47) NPC1RAB9AMAPTTHRBKDM4E
SCHEMBL14136973 0.66 PTGES (0.40) NPC1RAB9ADGAT1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1747196-B1 SUBSTITUTED ARYL ACYLTHIOUREAS AND RELATED COMPOUNDS; INHIBITORS OF VIRAL REPLICATION ACHILLION PHARMACEUTICALS INC (US) 2010-02-10 EP claimed